Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
Uterine FibroidVaginal Bleeding.
Interventions
DRUG

mifepristone vaginal tablets

Daily use of 10 mg administrated per vagina for 3 months

Trial Locations (2)

52621

Gynecolaoy department - Shiba Medical Center Tel Hashomer, Ramat Gan

Unknown

Rabin Medical Center, Petah Tikva

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioPro Medical Ltd

INDUSTRY

NCT00881140 - Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids | Biotech Hunter | Biotech Hunter